XML 196 R16.htm IDEA: XBRL DOCUMENT v3.22.4

Other Disclosures (Tables)

12 Months Ended

Dec. 31, 2022

Other Disclosures

Summary of remuneration of the Board of Directors and Executive Management

​

​	​	​	​	​	​	​
(DKK million)	​	2022	​	2021	​	2020
​	​	​	​	​	​	​
​	​	​	​	​	​	​
Wages and salaries	​	55	​	51	​	48
Share-based compensation expenses	​	70	​	58	​	43
Defined contribution plans	​	2	​	2	​	2
​	​	​	​	​	​	​
Total	​	127	​	111	​	93

​

Schedule of Remuneration to the Board of Directors

​

​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​
​	Base Board Fee			​	Committee Fees			​	Share-Based Compensation Expenses			​	Total			​
(DKK million)	2022	2021	2020	​	2022	2021	2020	​	2022	2021	2020	​	2022	2021	2020	​
​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​
Deirdre P. Connelly	1.2	1.2	1.1	​	0.5	0.5	0.5	​	0.9	0.7	0.7	​	2.6	2.4	2.3	​
Pernille Erenbjerg	0.9	0.9	0.7	​	0.4	0.4	0.4	​	0.7	0.5	0.4	​	2.0	1.8	1.5	​
Anders Gersel Pedersen	0.6	0.6	0.4	​	0.4	0.4	0.4	​	0.5	0.4	0.5	​	1.5	1.4	1.3	​
Paolo Paoletti	0.6	0.6	0.4	​	0.3	0.3	0.3	​	0.5	0.4	0.4	​	1.4	1.3	1.1	​
Rolf Hoffmann	0.6	0.6	0.4	​	0.3	0.4	0.3	​	0.5	0.4	0.5	​	1.4	1.4	1.2	​
Elizabeth O’Farrell1	0.5	-	-	​	0.2	-	-	​	0.6	-	-	​	1.3	-	-	​
Jonathan Peacock2	-	0.5	0.3	​	-	0.3	0.3	​	-	0.6	0.4	​	-	1.4	1.0	​
Mats Pettersson3	-	-	0.3	​	-	-	0.1	​	-	-	1.6	​	-	-	2.0	​
Mijke Zachariasse4	0.6	0.6	0.4	​	-	-	-	​	0.4	0.3	0.1	​	1.0	0.9	0.5	​
Martin Schultz4	0.5	-	-	​	-	-	-	​	-	-	-	​	0.5	-	-	​
Takahiro Hamatani4	0.5	-	-	​	-	-	-	​	-	-	-	​	0.5	-	-	​
Peter Storm Kristensen5	0.1	0.6	0.4	​	-	-	-	​	0.1	0.4	0.4	​	0.2	1.0	0.8	​
Rima Bawarshi Nassar5,6	0.1	0.6	0.1	​	-	-	-	​	0.1	0.2	-	​	0.2	0.8	0.1	​
Daniel J. Bruno6	-	-	0.3	​	-	-	-	​	-	-	(0.4)	​	-	-	(0.1)	​
​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​
Total	6.2	6.2	4.8	​	2.1	2.3	2.3	​	4.3	3.9	4.6	​	12.6	12.4	11.7	​
​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​

​

Schedule of executive compensation

​

​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​
​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​
​	Base Salary			​	Defined Contribution Plans			​	Other Benefits			​	Annual Cash Bonus			​	Share-Based Compensation Expenses			​	Total
(DKK million)	2022	2021	2020	​	2022	2021	2020	​	2022	2021	2020	​	2022	2021	2020	​	2022	2021	2020	​	2022	2021	2020
​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​
Jan van de Winkel	8.6	7.9	7.3	​	1.3	1.1	1.0	​	0.3	0.6	1.0	​	8.6	7.9	8.4	​	22.9	20.6	19.6	​	41.7	38.1	37.3
Anthony Pagano1	4.3	3.2	3.0	​	0.1	0.1	0.1	​	-	-	-	​	2.6	1.9	2.3	​	9.5	7.2	5.2	​	16.5	12.4	10.6
Anthony Mancini2	4.7	3.9	3.1	​	0.1	0.1	0.1	​	-	3.1	3.3	​	2.8	2.3	2.0	​	11.4	7.2	3.1	​	19.0	16.6	11.6
Judith Klimovsky	4.9	4.0	4.0	​	0.1	0.1	0.1	​	-	-	0.1	​	2.9	2.5	3.0	​	14.1	13.2	12.7	​	22.0	19.8	19.9
Tahamtan Ahmadi3	4.6	3.3	-	​	0.1	0.1	-	​	-	-	-	​	2.8	2.0	-	​	7.7	5.5	-	​	15.2	10.9	-
David A. Eatwell1	-	-	0.9	​	-	-	0.1	​	-	-	2.5	​	-	-	-	​	-	-	(2.3)	​	-	-	1.2
​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​
Total	27.1	22.3	18.3	​	1.7	1.5	1.4	​	0.3	3.7	6.9	​	19.7	16.6	15.7	​	65.6	53.7	38.3	​	114.4	97.8	80.6
​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​	​

​

1 – David A. Eatwell stepped down as CFO on February 29, 2020, and Anthony Pagano was appointed CFO and member of the Executive Management on March 1, 2020.

2 – Anthony Mancini was appointed Chief Operating Officer and member of the Executive Management in March 2020.

3 – Tahamtan Ahmadi was appointed Chief Medical Officer, Head of Experimental Medicines and member of the Executive Management in March 2021.

​

​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

Summary of fees to auditors

​

​	​	​	​	​	​	​
(DKK million)	​	2022	​	2021	​	2020
​	​	​	​	​	​	​
​	​	​	​	​	​	​
PricewaterhouseCoopers	​	​	​	​	​	​
Audit fees	​	5.8	​	5.8	​	4.9
Audit-related fees	​	2.0	​	1.8	​	1.0
Tax fees	​	-	​	-	​	0.3
All other fees	​	-	​	0.1	​	-
​	​	​	​	​	​	​
Total	​	7.8	​	7.7	​	6.2

​

Summary of adjustments to cash flow statement

​

​	​	​	​	​	​	​	​
(DKK million)	Note	​	2022	​	2021	​	2020
​	​	​	​	​	​	​	​
​	​	​	​	​	​	​	​
Adjustments for non-cash transactions:	​	​	​	​	​	​	​
Depreciation, amortization and impairment	3.1, 3.2, 3.3	​	362	​	248	​	259
Share-based compensation expenses	2.3, 4.6	​	439	​	310	​	200
Other	​	​	-	​	(32)	​	-
​	​	​	​	​	​	​	​
Total adjustments for non-cash transactions	​	​	801	​	526	​	459
​	​	​	​	​	​	​	​
Change in operating assets and liabilities:	​	​	​	​	​	​	​
Receivables	​	​	(2,213)	​	(1,074)	​	306
Deferred revenue	​	​	-	​	-	​	513
Other payables	​	​	283	​	304	​	168
​	​	​	​	​	​	​	​
Total change in operating assets and liabilities	​	​	(1,930)	​	(770)	​	987

​

X

- Definition

The tabular disclosure of amounts incurred by entity for provision of key management personnel .

+ References

No definition available.

+ Details

Name:	gmab_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelTableTextBlock
Namespace Prefix:	gmab_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

No definition.

+ References

No definition available.

+ Details

Name:	gmab_OtherDisclosureAbstract
Namespace Prefix:	gmab_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of amounts incurred by the entity for provision of key management personnel services that are provided by separate management entities. [Refer: Key management personnel of entity or parent [member]; Separate management entities [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 24
-IssueDate 2022-03-24
-Paragraph 18A
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_18A&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of compensation to the entity's auditors.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2022-03-24
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_DisclosureOfAuditorsRemunerationExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for a statement of cash flows.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2022-03-24
-Section Presentation of a statement of cash flows
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS07_g10-17__IAS07_g10-17_TI
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_DisclosureOfCashFlowStatementExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2022-03-24
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration